Tuesday, July 22, 2014
   

NEWS

September 28th, 2012- Scout Diagnostics received a National Institutes of Health Phase 1 STTR award to develop a serum based diagnostic test for Alzheimer's disease. 

Minimize
Scout Diagnostics
Scout Diagnostics is developing new diagnostic tools for early determination of Alzheimer Disease in patients.  This exciting new tool will allow researchers to test the efficacy of new treatments and will eventually allow for an early diagnosis, and thus begin treatment in the early stages of the disease, where treatments can be the most beneficial. Please take some time to browse this site and learn more about this exciting new technology and how it could be applied to your research efforts, or in your clinical setting.  Early diagnosis with high sensitivity and specificity is critical to the long term management of this devastating disease.  

 
Minimize
The Discovery
Scout Diagnostics has discovered a unique bio-marker that indicates the early onset of Alzheimer's disease.  The discoverers of this unique bio-marker have developed a diagnostic kit that can detect this bio-marker, allowing for the early diagnosis of Alzheimer's.  Early detection of Alzheimer's has been impossible up to this point, and the early the disease is detected the better the chances of treating the debilitating disease.  
Minimize
The Disease
Alzheimer's is a type of dementia that causes problems with memory, thinking and behavior. Symptoms usually develop slowly and get worse over time, becoming severe enough to interfere with daily tasks. Although the greatest known risk factor is increasing age, and the majority of people with Alzheimer's are 65 and older. But Alzheimer's is not just a disease of old age. Up to 5 percent of people with the disease have early-onset Alzheimer's.
Home   |   Technology   |   About Us
Copyright 2011 by Scout Diagnostics, LLC